Uterine Artery Embolization (UAE) in The Treatment of Symptomatic Leiomyoma: Effect On Ovarian Function, Clinical Symptoms And Its Complications: Effect of uterine artery embolization on leiomyoma
Background: To evaluate the effect of uterine artery embolization (UAE) on preservation of fertility in leiomyoma and its complications.
Methods: Thirty women with leiomyoma were included in the present study. Hormonal levels, leiomyoma size, patients’ symptoms and complications if developed were evaluated, both before and after UAE.
Results: There was no significant difference between the mean follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol levels, before and after UAE (p=0.431, p=0.672, p=0.772, respectively). Fibroids size measured before and after 6 months of UAE were 86.47 ± 28.42 cm and 59.80 ± 20.90 cm, respectively (p<0.001). None of the patients developed complications such as embolism, wound problems or necessity for hysterectomy. After UAE, symptoms such as hypermenorrhea, dysmenorrhea, dyspareunia, and dysuria decreased significantly among patients.
Conclusions: Our findings showed that UAE is an appropriate choice for patients with leiomyoma, to control and relieve symptoms, to reduce fibroid size, and finally to maintain fertility among those women.
This work is licensed under a Creative Commons Attribution 4.0 International License.